Potential new target to help treat Alzheimer’s and other neurological disorders

Scientists believe inhibiting a cell protein, called syntaphilin, may hold the key to enable regeneration of neurons, potentially providing a new treatment target for Alzheimer’s and other neurological diseases. This protein is believed to restrict the movement of mitochondria, the ‘powerhouse’ of the cell. Clinical researchers demonstrated when syntaphilin was removed from damaged sciatica nerves that contained non-functioning mitochondria, the mitochondria were mobilised, eventually restoring the neurons ability to repair itself. [Link]